NYSE:MRK • US58933Y1055
This MRK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
MRK gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 193 industry peers in the Pharmaceuticals industry. MRK scores excellent on profitability, but there are some minor concerns on its financial health. MRK is not valued too expensively and it also shows a decent growth rate. MRK also has an excellent dividend rating. With these ratings, MRK could be worth investigating further for dividend investing!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.69% | ||
| ROE | 36.71% | ||
| ROIC | 20.32% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 36.99% | ||
| PM (TTM) | 29.63% | ||
| GM | 77.69% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 3.17 | ||
| Altman-Z | 4.35 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.66 | ||
| Quick Ratio | 1.44 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.1 | ||
| Fwd PE | 22.23 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.88 | ||
| EV/EBITDA | 11.31 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.85% |
120.28
+0.45 (+0.38%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.85% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.1 | ||
| Fwd PE | 22.23 | ||
| P/S | 4.65 | ||
| P/FCF | 22.88 | ||
| P/OCF | 17.49 | ||
| P/B | 5.76 | ||
| P/tB | 19.97 | ||
| EV/EBITDA | 11.31 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.69% | ||
| ROE | 36.71% | ||
| ROCE | 23.54% | ||
| ROIC | 20.32% | ||
| ROICexc | 24.8% | ||
| ROICexgc | 44.78% | ||
| OM | 36.99% | ||
| PM (TTM) | 29.63% | ||
| GM | 77.69% | ||
| FCFM | 20.31% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 3.17 | ||
| Debt/EBITDA | 1.41 | ||
| Cap/Depr | 87.9% | ||
| Cap/Sales | 6.25% | ||
| Interest Coverage | 17.91 | ||
| Cash Conversion | 60.24% | ||
| Profit Quality | 68.56% | ||
| Current Ratio | 1.66 | ||
| Quick Ratio | 1.44 | ||
| Altman-Z | 4.35 |
ChartMill assigns a fundamental rating of 6 / 10 to MRK.
ChartMill assigns a valuation rating of 6 / 10 to MERCK & CO. INC. (MRK). This can be considered as Fairly Valued.
MERCK & CO. INC. (MRK) has a profitability rating of 8 / 10.
The financial health rating of MERCK & CO. INC. (MRK) is 5 / 10.
The dividend rating of MERCK & CO. INC. (MRK) is 7 / 10 and the dividend payout ratio is 42.6%.